$NICE News

NICE LTD - SPON ADR (NASDAQ:NICE): A Decent Value Play with Strong Fundamentals

NICE Ltd. (NASDAQ:NICE) Passes Quality-Focused Caviar Cruise Screen With Strong Profitability and Zero Debt

NICE: The Market Demands Innovation But Hates Change

Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $130

NICE Ltd. (NASDAQ:NICE) Fits the 'Decent Value' Profile with a P/E Ratio of 7.58

Citigroup Maintains Neutral on NICE, Lowers Price Target to $100

RBC Capital Maintains Outperform on NICE, Lowers Price Target to $130

Citizens Maintains Market Outperform on NICE, Lowers Price Target to $170

NICE Ltd. (NASDAQ:NICE): A Peter Lynch GARP Stock with a PEG of 0.61

Transcript: NICE Q1 2026 Earnings Conference Call

What's Going On With NICE Stock Wednesday?

NICE Raises FY2026 Adj EPS Guidance from $10.85-$11.05 to $10.98-$11.18 vs $10.94 Est; Affirms FY2026 Sales Guidance of $3.170B-$3.190B vs $3.192B Est

NICE Sees Q2 Adj EPS $2.60-$2.70 vs $2.65 Est; Sees Sales $761.000M-$771.000M vs $780.640M Est

NICE Q1 Adj. EPS $2.64 Beats $2.52 Estimate, Sales $768.617M Beat $764.239M Estimate

NICE LTD - SPON ADR (NASDAQ:NICE) Passes Key Peter Lynch GARP Investment Tests

NICE shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $184 to $119.

NICE shares are trading lower after Citigroup downgraded the stock from Buy to Neutral and lowered its price target from $184 to $119.

Citigroup Downgrades NICE to Neutral, Lowers Price Target to $119

NICE LTD - SPON ADR (NASDAQ:NICE) Presents a Compelling Value Investment Case

NICE LTD - SPON ADR (NASDAQ:NICE) Fits the Peter Lynch GARP Investment Model